|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Akateh C, Black SM, Conteh L, Miller ED,
Noonan A, Elliott E, Pawlik TM, Tsung A and Cloyd JM: Neoadjuvant
and adjuvant treatment strategies for hepatocellular carcinoma.
World J Gastroenterol. 25:3704–3721. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nakagawa S, Wei L, Song WM, Higashi T,
Ghoshal S, Kim RS, Bian CB, Yamada S, Sun X, Venkatesh A, et al:
Molecular liver cancer prevention in cirrhosis by organ
transcriptome analysis and lysophosphatidic acid pathway
inhibition. Cancer Cell. 30:879–890. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Han TS, Hur K, Cho HS and Ban HS:
Epigenetic associations between lncRNA/circRNA and miRNA in
hepatocellular carcinoma. Cancers (Basel). 12(2622)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Giannelli G, Koudelkova P, Dituri F and
Mikulits W: Role of epithelial to mesenchymal transition in
hepatocellular carcinoma. J Hepatol. 65:798–808. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
He S and Tang S: WNT/β-catenin signaling
in the development of liver cancers. Biomed Pharmacother.
132(110851)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Perugorria MJ, Olaizola P, Labiano I,
Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L and Banales JM:
Wnt-β-catenin signalling in liver development, health and disease.
Nat Rev Gastroenterol Hepatol. 16:121–136. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF
and Chen X: β-Catenin signaling in hepatocellular carcinoma. J Clin
Invest. 132(e154515)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
El Ashry ESH, Rashed N, Salama OM and
Saleh A: Components, therapeutic value and uses of myrrh.
Pharmazie. 58:163–168. 2003.PubMed/NCBI
|
|
10
|
Efferth T and Oesch F: Anti-inflammatory
and anti-cancer activities of frankincense: Targets, treatments and
toxicities. Semin Cancer Biol. 80:39–57. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Suliman RS, Alghamdi SS, Ali R, Aljatli D,
Aljammaz NA, Huwaizi S, Suliman R, Kahtani KM, Albadrani GM,
Barhoumi T, et al: The role of myrrh metabolites in cancer,
inflammation, and wound healing: Prospects for a multi-targeted
drug therapy. Pharmaceuticals (Basel). 15(944)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen P, Li X, Zhang R, Liu S, Xiang Y,
Zhang M, Chen X, Pan T, Yan L, Feng J, et al: Combinative treatment
of β-elemene and cetuximab is sensitive to KRAS mutant colorectal
cancer cells by inducing ferroptosis and inhibiting
epithelial-mesenchymal transformation. Theranostics. 10:5107–5119.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jiang G, Xiao X, Zeng Y, Nagabhushanam K,
Majeed M and Xiao D: Targeting beta-Catenin signaling to induce
apoptosis in human breast cancer cells by z-Guggulsterone and
Gugulipid extract of Ayurvedic medicine plant Commiphora
mukul. BMC Complement Altern Med. 13(203)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu
C, Wang C and Ye L: Wnt/β-catenin signaling in cancers and targeted
therapies. Signal Transduct Target Ther. 6(307)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hu D, Wang C, Li F, Su S, Yang N, Yang Y,
Zhu C, Shi H, Yu L, Geng X, et al: A combined water extract of
frankincense and myrrh alleviates neuropathic pain in mice via
modulation of TRPV1. Neural Plast. 2017(3710821)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Brabletz S, Schuhwerk H, Brabletz T and
Stemmler MP: Dynamic EMT: A multi-tool for tumor progression. EMBO
J. 40(e108647)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cao B, Wei XC, Xu XR, Zhang HZ, Luo CH,
Feng B, Xu RC, Zhao SY, Du XJ, Han L and Zhang DK: Seeing the
unseen of the combination of two natural resins, frankincense and
myrrh: Changes in chemical constituents and pharmacological
activities. Molecules. 24(3076)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guo Q, Lin J, Liu R, Gao Y, He S, Xu X,
Hua B, Li C, Hou W, Zheng H and Bao Y: Review on the applications
and molecular mechanisms of Xihuang pill in tumor treatment. Evid
Based Complement Alternat Med. 2015(854307)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7(re8)2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu HP, Gao ZH, Cui SX, Wang Y, Li BY, Lou
HX and Qu XJ: Chemoprevention of intestinal adenomatous polyposis
by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Int J
Cancer. 132:2667–2681. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mohamed EA, Ahmed HI, Zaky HS and Badr AM:
Boswellic acids ameliorate neurodegeneration induced by AlCl3: The
implication of Wnt/β-catenin pathway. Environ Sci Pollut Res Int.
29:76135–76143. 2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ren P, Ren X, Cheng L and Xu L:
Frankincense, pine needle and geranium essential oils suppress
tumor progression through the regulation of the AMPK/mTOR pathway
in breast cancer. Oncol Rep. 39:129–137. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sun M, Hua J, Liu G, Huang P, Liu N and He
X: Myrrh induces the apoptosis and inhibits the proliferation and
migration of gastric cancer cells through down-regulating
cyclooxygenase-2 expression. Biosci Rep.
40(BSR20192372)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Tang X, Sui X, Weng L and Liu Y: SNAIL1:
Linking tumor metastasis to immune evasion. Front Immunol.
12(724200)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Casas E, Kim J, Bendesky A, Ohno-Machado
L, Wolfe CJ and Yang J: Snail2 is an essential mediator of
Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71:245–254. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhu QQ, Ma C, Wang Q, Song Y and Lv T: The
role of TWIST1 in epithelial-mesenchymal transition and cancers.
Tumour Biol. 37:185–197. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Peiffer DS, Wyatt D, Zlobin A, Piracha A,
Ng J, Dingwall AK, Albain KS and Osipo C: DAXX suppresses
tumor-initiating cells in estrogen receptor-positive breast cancer
following endocrine therapy. Cancer Res. 79:4965–4977.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang Z, Li Z, Wu Q, Li C, Li J, Zhang Y,
Wang C and Sun S and Sun S: DNER promotes epithelial-mesenchymal
transition and prevents chemosensitivity through the Wnt/β-catenin
pathway in breast cancer. Cell Death Dis. 11(642)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang Y and Wang X: Targeting the
Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol.
13(165)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gao C and Chen YG: Dishevelled: The hub of
Wnt signaling. Cell Signal. 22:717–727. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Gan X, Wang J, Xi Y, Wu Z, Li Y and Li L:
Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to
stabilization of beta-catenin-TCF interaction. J Cell Biol.
180:1087–1100. 2008.PubMed/NCBI View Article : Google Scholar
|
